Stromal Vascular Fraction Market
Stromal Vascular Fraction Market : Table of Content
- Report code : PMRREP20914 |
- Industry : Life Sciences & Transformational Health |
- Published On : Mar-2020 |
- Pages : 183 Pages |
-
Format :
1. Executive Summary
1.1. Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Dynamics
3.1. Macro-Economic Factors
3.1.1. Demand Side Drivers
3.1.2. Supply Side Drivers
3.1.3. Restraints
3.1.4. Opportunity Analysis
3.1.5. Trends
4. Market Context
4.1. Stromal Vascular Fraction Forecast Factors - Relevance And Impact
4.2. Parent Market Analysis
5. Global Stromal Vascular Fraction Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
5.2.3. Market Value Comparison
6. Global Stromal Vascular Fraction Market Analysis 2014-2018 and Forecast 2019-2029, by Product
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Product, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2019 - 2029
6.3.1. SVF Aspiration Products
6.3.2. SVF Transfer Products
6.3.3. SVF Isolation Products
6.3.3.1. Enzymatic Isolation Products
6.3.3.2. Non-enzymatic Isolation Products
6.3.3.3. Automated POC Devices
6.4. Market Attractiveness Analysis By Product
7. Global Stromal Vascular Fraction Market Analysis 2014-2018 and Forecast 2019-2029, by Application
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Application, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2019 - 2029
7.3.1. Cosmetic Applications
7.3.2. Orthopedic Applications
7.3.3. Soft Tissue Applications
7.3.4. Others
7.4. Market Attractiveness Analysis By Application
8. Global Stromal Vascular Fraction Market Analysis 2014-2018 and Forecast 2019-2029, by End User
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By End User, 2014-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 - 2029
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Stem Cell Banks/Laboratories
8.3.4. Others
8.4. Market Attractiveness Analysis By End User
9. Global Stromal Vascular Fraction Market Analysis 2014-2018 and Forecast 2019-2029, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia-Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Stromal Vascular Fraction Market Analysis 2014-2018 and Forecast 2019-2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Product
10.4.3. By Application
10.4.4. By End User
10.5. Market Key Participants and Intensity Mapping
11. Latin America Stromal Vascular Fraction Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
11.3.1. By Country
11.3.1.1. Mexico
11.3.1.2. Brazil
11.3.1.3. Rest of Latin America
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product
11.4.3. By Application
11.4.4. By End User
11.5. Market Key Participants and Intensity Mapping
12. Europe Stromal Vascular Fraction Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. Russia
12.3.1.7. Rest of Europe
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Application
12.4.4. By End User
12.5. Market Key Participants and Intensity Mapping
13. Asia Pacific Stromal Vascular Fraction Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
13.3.1. By Country
13.3.1.1. China
13.3.1.2. India
13.3.1.3. Australia
13.3.1.4. Japan
13.3.1.5. ASEAN
13.3.1.6. South Korea
13.3.1.7. Rest of Asia Pacific
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Application
13.4.4. By End User
13.5. Market Key Participants and Intensity Mapping
14. Middle East and Africa Stromal Vascular Fraction Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
14.3.1. By Country
14.3.1.1. GCC Countries
14.3.1.2. South Africa
14.3.1.3. Rest of MEA
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market Key Participants and Intensity Mapping
15. Competition Analysis
15.1. Competition Dashboard
15.2. Competition Deep Dive
15.2.1. Cytori Therapeutics Inc.
15.2.1.1. Overview
15.2.1.2. Product Portfolio
15.2.1.3. Profitability by Market Segments (Product/Application/Region)
15.2.1.4. Sales Footprint
15.2.1.5. Strategy Overview
15.2.1.5.1. Marketing Strategy
15.2.1.5.2. Product Strategy
15.2.1.5.3. Application Strategy
15.2.2. IntelliCell BioSciences Inc.
15.2.2.1. Overview
15.2.2.2. Product Portfolio
15.2.2.3. Profitability by Market Segments (Product/Application/Region)
15.2.2.4. Sales Footprint
15.2.2.5. Strategy Overview
15.2.2.5.1. Marketing Strategy
15.2.2.5.2. Product Strategy
15.2.2.5.3. Application Strategy
15.2.3. Cellular Biomedicines Group, Inc
15.2.3.1. Overview
15.2.3.2. Product Portfolio
15.2.3.3. Profitability by Market Segments (Product/Application/Region)
15.2.3.4. Sales Footprint
15.2.3.5. Strategy Overview
15.2.3.5.1. Marketing Strategy
15.2.3.5.2. Product Strategy
15.2.3.5.3. Application Strategy
15.2.4. GE Healthcare (Biosafe Group SA)
15.2.4.1. Overview
15.2.4.2. Product Portfolio
15.2.4.3. Profitability by Market Segments (Product/Application/Region)
15.2.4.4. Sales Footprint
15.2.4.5. Strategy Overview
15.2.4.5.1. Marketing Strategy
15.2.4.5.2. Product Strategy
15.2.4.5.3. Application Strategy
15.2.5. Lifecell Corporation (Allergen PLC)
15.2.5.1. Overview
15.2.5.2. Product Portfolio
15.2.5.3. Profitability by Market Segments (Product/Application/Region)
15.2.5.4. Sales Footprint
15.2.5.5. Strategy Overview
15.2.5.5.1. Marketing Strategy
15.2.5.5.2. Product Strategy
15.2.5.5.3. Application Strategy
15.2.6. Tissue Genesis Inc
15.2.6.1. Overview
15.2.6.2. Product Portfolio
15.2.6.3. Profitability by Market Segments (Product/Application/Region)
15.2.6.4. Sales Footprint
15.2.6.5. Strategy Overview
15.2.6.5.1. Marketing Strategy
15.2.6.5.2. Product Strategy
15.2.6.5.3. Application Strategy
15.2.7. InGeneron, Inc.
15.2.7.1. Overview
15.2.7.2. Product Portfolio
15.2.7.3. Profitability by Market Segments (Product/Application/Region)
15.2.7.4. Sales Footprint
15.2.7.5. Strategy Overview
15.2.7.5.1. Marketing Strategy
15.2.7.5.2. Product Strategy
15.2.7.5.3. Application Strategy
15.2.8. Human med AG
15.2.8.1. Overview
15.2.8.2. Product Portfolio
15.2.8.3. Profitability by Market Segments (Product/Application/Region)
15.2.8.4. Sales Footprint
15.2.8.5. Strategy Overview
15.2.8.5.1. Marketing Strategy
15.2.8.5.2. Product Strategy
15.2.8.5.3. Application Strategy
15.2.9. MEDICAN CO., LTD
15.2.9.1. Overview
15.2.9.2. Product Portfolio
15.2.9.3. Profitability by Market Segments (Product/Application/Region)
15.2.9.4. Sales Footprint
15.2.9.5. Strategy Overview
15.2.9.5.1. Marketing Strategy
15.2.9.5.2. Product Strategy
15.2.9.5.3. Application Strategy
16. Assumptions and Acronyms Used
17. Research Methodology
List of Tables:
Table 01: Comparison of Cost of Processing Adipose Aspirates Using New Automated Techniques Vs. Traditional Centrifuge Methods
Table 02: Pipeline of Cellular Therapies Using SVF (1/3)
Table 03: Pipeline of Cellular Therapies Using SVF (2/3)
Table 04: Pipeline of Cellular Therapies Using SVF (3/3)
Table 05: Stromal Vascular Fraction Market Value (US$ Mn) Growth Comparison
Table 06: Global Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Product
Table 07: Global Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Application
Table 08: Global Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By End User
Table 09: Global Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Region
Table 10: North America Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 11: North America Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Product
Table 12: North America Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Application
Table 13: North America Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By End User
Table 14: Latin America Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 15: Latin America Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Product
Table 16: Latin America Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Application
Table 17: Latin America Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By End User
Table 18: Europe Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 19: Europe Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Product
Table 20: Europe Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Application
Table 21: Europe Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By End User
Table 22: Asia Pacific Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 23: Asia Pacific Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Product
Table 24: Asia Pacific Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Application
Table 25: Asia Pacific Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By End User
Table 26: Middle East and Africa Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 27: Middle East and Africa Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Product
Table 28: Middle East and Africa Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Application
Table 29: Middle East and Africa Stromal Vascular Fraction Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By End User
List of Figures:
Figure 01: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 02: Biotechnology & Pharmaceutical Mergers and Acquisition and Number of deals (2012-2018)
Figure 03: Trends in Venture Capital Funding (US$ Bn) in Biotechnology Industry (2012-2017)
Figure 04: Distribution of SVF Derived Cell Therapy Clinical Trials By Phase
Figure 05: Steps in Stromal Vascular Fraction Preparation for Patient Injection
Figure 06: Opportunity for Suppliers of Consumables
Figure 07: Number of Scientific Publication Regarding Development of Stromal Vascular Fraction for Therapeutic Application (2010-2018)
Figure 08: Global Distribution of Stromal Vascular Fraction Market Install Base, By Region (2018)
Figure 09: Global Distribution of Stromal Vascular Fraction Procedures, By Region (2018)
Figure 10: Global Cell Therapy and Tissue Processing Systems Market Analysis and Share of Stromal Vascular Fraction Market (2018)
Figure 11: Global Stromal Vascular Fraction Market Value Analysis (US$ Mn), 2014–2018
Figure 12: Global Stromal Vascular Fraction Market Value Forecast (US$ Mn), 2019–2029
Figure 13: Global Stromal Vascular Fraction Market Absolute $ Opportunity, 2019–2029
Figure 14: Comparison April 2018 and February 2020, Y-o-Y Forecast
Figure 15: Global Stromal Vascular Fraction Market Share Analysis (%), By Product, 2019 & 2029
Figure 16: Global Stromal Vascular Fraction Market Y-o-Y Analysis (%), By Product, 2019–2029
Figure 17: Global Stromal Vascular Fraction Market Attractiveness Analysis By Product, 2019–2029
Figure 18: Global Stromal Vascular Fraction Market Share Analysis (%), By Application, 2019 & 2029
Figure 19: Global Stromal Vascular Fraction Market Y-o-Y Analysis (%), By Application, 2019–2029
Figure 20: Global Stromal Vascular Fraction Market Attractiveness Analysis By Application, 2019–2029
Figure 21: Global Stromal Vascular Fraction Market Share Analysis (%), By End User, 2019 & 2029
Figure 22: Global Stromal Vascular Fraction Market Y-o-Y Analysis (%), By End User, 2019–2029
Figure 23: Global Stromal Vascular Fraction Market Attractiveness Analysis By End User, 2019–2029
Figure 24: Global Stromal Vascular Fraction Market Share Analysis (%), By Region Type, 2019 & 2029
Figure 25: Global Stromal Vascular Fraction Market Y-o-Y Analysis (%), By Region Type, 2019–2029
Figure 26: Global Stromal Vascular Fraction Market Attractiveness Analysis By Region, 2019–2029
Figure 27: North America Stromal Vascular Fraction Market Value Share, By Country (2019)
Figure 28: North America Stromal Vascular Fraction Market Value Share, By Products (2019)
Figure 29: North America Stromal Vascular Fraction Market Value Share, By Application (2019)
Figure 30: North America Stromal Vascular Fraction Market Value Share, By End User (2019)
Figure 31: North America Stromal Vascular Fraction Market Value (US$ Mn) 2019E and 2029F
Figure 32: North America Stromal Vascular Fraction Market Value Analysis (US$ Mn), 2014–2018
Figure 33: North America Stromal Vascular Fraction Market Value Forecast (US$ Mn), 2019–2029
Figure 34: North America Stromal Vascular Fraction Market Attractiveness Analysis By Country, 2019–2029
Figure 35: North America Stromal Vascular Fraction Market Attractiveness Analysis By Product, 2019–2029
Figure 36: North America Stromal Vascular Fraction Market Attractiveness Analysis By Application, 2019–2029
Figure 37: North America Stromal Vascular Fraction Market Attractiveness Analysis By End User, 2019–2029
Figure 38: Latin America Stromal Vascular Fraction Market Value Share, By Country (2019)
Figure 39: Latin America Stromal Vascular Fraction Market Value Share, By Products (2019)
Figure 40: Latin America Stromal Vascular Fraction Market Value Share, By Application (2019)
Figure 41: Latin America Stromal Vascular Fraction Market Value Share, By End User (2019)
Figure 42: Latin America Stromal Vascular Fraction Market Value (US$ Mn) 2019E and 2029F
Figure 43: Latin America Stromal Vascular Fraction Market Value Analysis (US$ Mn), 2014–2018
Figure 44: Latin America Stromal Vascular Fraction Market Value Forecast (US$ Mn), 2019–2029
Figure 45: Latin America Stromal Vascular Fraction Market Attractiveness Analysis By Country, 2019–2029
Figure 46: Latin America Stromal Vascular Fraction Market Attractiveness Analysis By Product, 2019–2029
Figure 47: Latin America Stromal Vascular Fraction Market Attractiveness Analysis By Application, 2019–2029
Figure 48: Latin America Stromal Vascular Fraction Market Attractiveness Analysis By End User, 2019–2029
Figure 49: Europe Stromal Vascular Fraction Market Value Share, By Country (2019)
Figure 50: Europe Stromal Vascular Fraction Market Value Share, By Products (2019)
Figure 51: Europe Stromal Vascular Fraction Market Value Share, By Application (2019)
Figure 52: Europe Stromal Vascular Fraction Market Value Share, By End User (2019)
Figure 53: Europe Stromal Vascular Fraction Market Value (US$ Mn) 2019E and 2029F
Figure 54: Europe Stromal Vascular Fraction Market Value Analysis (US$ Mn), 2014–2018
Figure 55: Europe Stromal Vascular Fraction Market Value Forecast (US$ Mn), 2019–2029
Figure 56: Europe Stromal Vascular Fraction Market Attractiveness Analysis By Country, 2019–2029
Figure 57: Europe Stromal Vascular Fraction Market Attractiveness Analysis By Product, 2019–2029
Figure 58: Europe Stromal Vascular Fraction Market Attractiveness Analysis By Application, 2019–2029
Figure 59: Europe Stromal Vascular Fraction Market Attractiveness Analysis By End User, 2019–2029
Figure 60: Asia Pacific Stromal Vascular Fraction Market Value Share, By Country (2019)
Figure 61: Asia Pacific Stromal Vascular Fraction Market Value Share, By Products (2019)
Figure 62: Asia Pacific Stromal Vascular Fraction Market Value Share, By Application (2019)
Figure 63: Asia Pacific Stromal Vascular Fraction Market Value Share, By End User (2019)
Figure 64: Asia Pacific Stromal Vascular Fraction Market Value (US$ Mn) 2019E and 2029F
Figure 65: Asia Pacific Stromal Vascular Fraction Market Value Analysis (US$ Mn), 2014–2018
Figure 66: Asia Pacific Stromal Vascular Fraction Market Value Forecast (US$ Mn), 2019–2029
Figure 67: Asia Pacific Stromal Vascular Fraction Market Attractiveness Analysis By Country, 2019–2029
Figure 68: Asia Pacific Stromal Vascular Fraction Market Attractiveness Analysis By Product, 2019–2029
Figure 69: Asia Pacific Stromal Vascular Fraction Market Attractiveness Analysis By Application, 2019–2029
Figure 70: Asia Pacific Stromal Vascular Fraction Market Attractiveness Analysis By End User, 2019–2029
Figure 71: MEA Stromal Vascular Fraction Market Value Share, By Country (2019)
Figure 72: MEA Stromal Vascular Fraction Market Value Share, By Products (2019)
Figure 73: MEA Stromal Vascular Fraction Market Value Share, By Application (2019)
Figure 74: MEA Stromal Vascular Fraction Market Value Share, By End User (2019)
Figure 75: MEA Stromal Vascular Fraction Market Value (US$ Mn) 2019E and 2029F
Figure 76: Middle East and Africa Stromal Vascular Fraction Market Value Analysis (US$ Mn), 2014–2018
Figure 77: Middle East and Africa Stromal Vascular Fraction Market Value Forecast (US$ Mn), 2019–2029
Figure 78: Middle East and Africa Stromal Vascular Fraction Market Attractiveness Analysis By Country, 2019–2029
Figure 79: Middle East and Africa Stromal Vascular Fraction Market Attractiveness Analysis By Product, 2019–2029
Figure 80: Middle East and Africa Stromal Vascular Fraction Market Attractiveness Analysis By Application, 2019–2029
Figure 81: Middle East and Africa Stromal Vascular Fraction Market Attractiveness Analysis By End User, 2019–2029
